ArticleThe journal of allergy and clinical immunology. Global2025
Subcutaneous immunotherapy in a patient taking ofatumumab for multiple sclerosis and upadacitinib for atopic dermatitis.
Twan Sia et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.